Dr. James B. Fleming, MD

Dr. Fleming practices at OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth.

Dr. Fleming's NPI, 1245448083, was assigned on May 17, 2007. Dr. Fleming graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2005. Dr. Fleming holds Ohio license 35.099596.

Dr. Fleming's primary practice is OhioHealth Riverside Methodist Hospital, at 3535 Olentangy River Rd, Columbus, OH 43214 in Franklin County. The practice phone is (614) 566-5000.

Dr. Fleming's primary practice is OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth. Dr. Fleming is also affiliated with OhioHealth Grant Medical Center. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Fleming to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Fleming is licensed in Ohio.

CMS data shows 423 Medicare services from Dr. Fleming across 12 procedure codes in 2024, for 291 Medicare patients. Medicare paid $71,065 for them.

CMS counts 291 Medicare patients who saw Dr. Fleming in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 68, with 51% women.

In 2024, Dr. Fleming wrote 146 Medicare Part D claims for 57 patients. 100% of them were for generic drugs. CMS names the drug for 111 of them, across 5 drugs with 11 or more claims each, at $611 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Fleming for performance year 2024, reported as part of a group. Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fleming as offering telehealth. CMS counts 91 procedures of spinal fusion by Dr. Fleming, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Fleming, published from 2011 to 2013. 2011 was the busiest year, with 2. The most frequent topics are Cerebral Angiography, Embolization, Therapeutic and Neurosurgical Procedures. Dr. Fleming has published most often in J Neurosurg. Dr. Fleming's most frequent co-authors are Mark R. Harrigan, Beverly Claire Walters, MD and Christoph Johannes Griessenauer, MD.

Dmand AI links Dr. Fleming to 2 clinical trials. Conditions studied include Cerebral Hemorrhage and Intracranial Hemorrhages. Open Payments lists research payments to Dr. Fleming that name 1 trial.

CMS Open Payments shows 55 general payments to Dr. Fleming from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Mazor Robotics Inc. paid the most, $1,499. It also lists 1 research payment totaling $428 in 2018, naming 1 clinical trial.

Dr. Fleming graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2005.